U.S. Marine and Shipping Stock News

Fortune Brands Innovations, Inc. recently appointed Jesse G. Singh as Chief Executive Officer and Board member, with former Interim CEO David Barry moving into the Executive Vice President and Chief Operating Officer role. Singh’s long experience leading building-products, consumer and manufacturing businesses, including at The AZEK Company and 3M, introduces a new leadership profile that could influence Fortune Brands’ operational priorities and product focus. We’ll now examine how Singh’s...

Critical Metals Corp. recently closed two shelf registrations totaling about US$240.96 million for over 23 million ordinary shares and completed the earlier acquisition of the Ocean Endeavour, a 180-passenger vessel, for EUR 7.5 million to support its Qaqortoq, Greenland project. The Ocean Endeavour gives the company an integrated accommodation and transport hub that aims to ease pressure on local infrastructure while embedding Greenlandic businesses into its supply chain. We’ll now examine...

Abacus Global Management, Inc. recently amended its December 2024 credit agreement, securing an additional US$75,000,000 in incremental term loans for a total of US$225,000,000 in aggregate principal, while also announcing the June 30, 2026 retirement-related resignation of director Sean McNealy, who will remain as an advisor during a transition period. This combination of expanded long-term debt capacity and planned board turnover highlights how Abacus Global Management is adjusting its...

Spin Master Corp.’s announcement of Lionsgate Studios (LION) as a collaborator on its Hellbreak horror trading card game has drawn fresh attention to the studio’s intellectual property and licensing reach. See our latest analysis for Lionsgate Studios. At a share price of $13.47, Lionsgate Studios has recently given back some momentum, with the 7 day share price return down 8.12% and the 30 day share price return down 5.94%. However, the 90 day share price return of 21.68% and 1 year total...

D-MARKET Electronic Services & Trading has completed its planned leadership transition, with former Chief Commercial Officer Ender Özgün becoming Hepsiburada’s CEO and Hakan Karadogan taking over as CEO of the Delivery business from July 1, 2026, both reporting to Chairman Mikheil Lomtadze and the Board. This dual-CEO structure concentrates leadership on Hepsiburada’s core commerce and delivery operations, potentially influencing how investors view execution on logistics efficiency, customer...

Knight-Swift Transportation Holdings (KNX) is back in focus after analysts raised full-year earnings estimates by 12% over the past 3 months, alongside stock performance that has outpaced the sector and a favorable research ranking. See our latest analysis for Knight-Swift Transportation Holdings. Despite a recent pullback, with a 1 day share price return down 2.57% and a 30 day share price return down 7.79%, Knight-Swift Transportation Holdings still shows strong momentum, supported by a 90...

In early July 2026, Nova Ltd. announced that a global foundry selected its Nova WMC platform as the tool of record for multilayer measurements in advanced semiconductor packaging, following a competitive evaluation. This win underlines how Nova’s modular, high-fidelity WMC architecture is becoming embedded in cutting-edge packaging flows, potentially supporting wider deployment as customers expand capacity. We’ll now explore how this new tool-of-record win in advanced packaging could...

Scholar Rock Holding (SRRK) has drawn fresh attention after recent share price moves, prompting investors to revisit how its clinical-stage pipeline and current financial profile line up with expectations in the neuromuscular disease space. See our latest analysis for Scholar Rock Holding. At a latest share price of US$56.71, Scholar Rock Holding has given investors a 30 day share price return of 28.36% and a year to date share price return of 32.50%. The 1 year total shareholder return of...

Quality of life is becoming a front line issue for companies deciding where to hire, build and invest, and that shift is starting to show up in healthcare services and infrastructure stocks. As employers put more weight on access to care, inclusive communities and worker protections, some companies look better placed than others to serve this demand. This article walks through 3 stocks from our Healthcare Services and Infrastructure screener that appear particularly exposed to these themes,...

Kosmos Energy recently reported that its Jubilee field in Ghana delivered higher output with the J76 well contributing about 20,000 barrels of oil per day and strong LNG cargo liftings from the Greater Tortue Ahmeyim project in Mauritania and Senegal, while also completing the sale of its Ceiba and Okume assets in Equatorial Guinea. At the same time, Kosmos faced a new Sell rating focused on leverage and execution risk, highlighting the tension between improving operational performance and...

Ascendis Pharma (NasdaqGS:ASND) reported new 104 week data from its pivotal ApproaCH trial of once weekly TransCon CNP in children with achondroplasia. The long term results show sustained improvements in lower extremity alignment and growth outcomes, with continued safety and tolerability over two years of treatment. The company also highlighted that YUVIWEL, the commercial name for TransCon CNP, is approved in the US and remains under regulatory review at the EMA in Europe. Ascendis...

Viper Energy (VNOM) recently closed a shelf registration tied to an offering of 3,691,796 Class A common shares, totaling about US$156.6 million. This event can shape perceptions of its capital-raising flexibility. See our latest analysis for Viper Energy. Against the backdrop of this shelf registration closing, Viper Energy’s recent share price performance has been mixed, with a 7 day share price return of 3.14%, a 30 day share price return down 5.30%, and a 1 year total shareholder return...

VNET Group has delivered a very large 3 year return while the broader valuation checks point to a mixed picture rather than a clear bargain or clear overvaluation at the current share price of US$8.01. Over the past 3 years, VNET Group has returned about 188.1%, which puts past investors well ahead but raises the bar for what needs to go right from here. China's planned US$295b buildout of data center and artificial intelligence infrastructure can support expectations for VNET Group's future...

Delta Air Lines (DAL) has just posted Q2 2026 revenue of US$19.8 billion with basic EPS of US$2.45 and net income of US$1.6 billion, setting a clear marker for this earnings season. Over the past few quarters, revenue has moved from US$14.0 billion in Q1 2025 to US$15.9 billion in Q1 2026 and now US$19.8 billion in Q2 2026. Quarterly EPS has ranged from US$0.37 in Q1 2025 to US$3.28 in Q2 2025 and US$2.45 this quarter. With trailing 12 month EPS at US$6.07 and net income of US$4.0 billion,...

In recent days, CSW Industrials has drawn attention after Zacks Equity Research highlighted the company as a top-ranked stock with an expected 20.6% year-over-year earnings increase, supported by a history of earnings beats in three of the last four quarters. At the same time, differing valuation models and recent insider selling have created a mixed picture, underscoring how much of the current investment case rests on CSW Industrials continuing to deliver strong cash flows and margins to...

Recent commentary has highlighted ongoing margin pressures at BJ's Wholesale Club Holdings, including below-industry gross and operating margins and slower revenue growth, intensifying scrutiny of its cost structure and competitive position. This focus on weaker profitability versus larger warehouse rivals raises fresh questions about how BJ’s scale influences its ability to invest in marketing and long-term competitiveness. Now we’ll explore how concerns over BJ’s below-industry profit...

Collegium Pharmaceutical (COLL) has drawn fresh interest after recent trading left the stock at about $35.23, with returns mixed across different time frames and investors reassessing how its pain management portfolio supports the current valuation. See our latest analysis for Collegium Pharmaceutical. The recent dip in Collegium Pharmaceutical's share price, with a 1-day share price return of 1.62% down and a 7-day share price return of 4.86% down, sits against a mixed picture where the...

Why TG Therapeutics Stock Is Back in Focus TG Therapeutics (TGTX) has attracted fresh attention after launching a Phase 2 trial of BRIUMVI in adults with treatment-resistant schizophrenia. This extends its CD20-focused approach beyond multiple sclerosis and into severe psychiatric disease. See our latest analysis for TG Therapeutics. The BRIUMVI schizophrenia trial arrives after a strong run in TG Therapeutics' share price, with a 90 day share price return of 69.04% and year to date share...

Founder led companies can be especially interesting when inflation, rates and growth signals are pulling in different directions, because these leaders typically have both reputation and wealth tied to long term outcomes, not just quarterly bonuses. With central banks weighing softer inflation data against volatile energy prices and uneven growth, many investors are looking for businesses where decision makers are deeply aligned with shareholders. This Founder-Led Companies screener focuses...

Williams Companies stock has delivered very strong gains over the past five years, yet the current valuation checks lean expensive. This raises the question of how much of the story is already reflected in the price. Over 5 years, Williams Companies has returned about 273%, which signals that long term shareholders have already enjoyed very substantial value creation. The pending US$5.5b Momentum Midstream acquisition can support expectations for future cash flows, but the integration...

Bio-Rad Laboratories (BIO) has introduced its QX700 System-compatible Vericheck ddPCR Kit portfolio, targeting quality control workflows in advanced cell and gene therapy development and broader biopharma applications, an event that may influence how investors assess the stock. See our latest analysis for Bio-Rad Laboratories. At a share price of US$296.11, Bio-Rad Laboratories has seen modest recent momentum, with a 30-day share price return of 1.75% and a 90-day gain of 6.04%. The 1-year...

Axon Enterprise (NasdaqGS:AXON) has appointed Vivek Mohindra and Eiso Kant as independent directors to its board. The new directors bring experience in large technology companies, AI, and cloud infrastructure startups. The appointments are intended to deepen Axon's governance and oversight around AI and enterprise technology. Axon Enterprise, known for its public safety hardware and software platforms, is trying to position itself more firmly at the intersection of policing tools and AI...

In late June 2026, W. P. Carey Inc. completed a fixed-income offering of 5.200% senior unsecured fixed-rate notes due September 15, 2036, raising about US$346.55 million at a modest discount to par. This long-dated, callable bond issue highlights how W. P. Carey is using unsecured debt to support its capital needs while balancing flexibility and funding costs. We’ll now explore how this new US$346.55 million senior unsecured bond affects W. P. Carey’s investment narrative and risk-reward...

Government pressure on US companies to cut prices, rising fuel costs linked to war with Iran, and fresh tariffs are making inflation a political and corporate headache. Utilities sit at the crossroads of essential services and policy risk, where price controls, tariffs and input costs can all affect how stable a stock feels in a portfolio. This article looks at how those forces connect to a curated screener of larger US utilities stocks, and highlights three stocks that appear positively...